Sino Biological, Inc.

1400 Liberty Ridge Drive
Suite 101
Wanye,  PA  19087

United States
https://www.sinobiological.com

• Booth: 5128

Sino Biological is a leading supplier of recombinant antigens and antibodies. We support the academic, biotech, pharma, and diagnostic companies with a large selection of reagents in oncology, infectious disease, and other research areas. The ProVir collection features the world’s largest bank of viral antigens. In 2020, our SAS-COV-2 reagents have been used to manufacture multiple FDA-approved COVID19 testing kits. We also provide services for antibody and protein production.

 Press Releases

• Sino Biological Finalizes the Acquisition of SignalChem Biotech, Strengthen (Jul 29, 2024)
  Beijing, China – April 27, 2024 — Sino Biological, Inc. ("Sino Biological" or the "Company”), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), specializing in biological research reagents and related technical contract research services, has successfully concluded its acquisition of Vancouver-based Canadian biotechnology company SignalChem Biotech Inc. (“SCB” or "SignalChem”). Sino Biological has acquired 100% of SCB shares in a deal valued at $48M USD, inclusive of all assets, assumed indebtedness, and net of cash deposits.

• Sino Biological Announces the Opening of Its New US-Based Center for Biopro (Jul 29, 2024)
  Houston, Texas – October 9^th, 2023 — Sino Biological, Inc.(“Sino Biological” or the “Company”), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), which provides biological research reagents and related technical contract research services, is pleased to announce the formal opening of its new Center for Bioprocessing (C4B) in Houston, Texas USA at Levit Green, adjacent to the world-renowned Texas Medical Center.